Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 7
Submit an article Journal homepage
1,862
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

Cristina MaccalliResearch Branch, Division of Translational Medicine, Sidra Medical and Research Center, Doha, QatarCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6737-4715
ORCID Icon,
Diana GiannarelliUnit of Statistics, Regina Elena National Cancer Institute, Rome, Italy
,
Carla ChiarucciMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;University of Siena, Siena, Italy
,
Ornella CutaiaMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;University of Siena, Siena, Italy
,
Gianluca GiacobiniMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;University of Siena, Siena, Italy
,
Wouter HendrickxResearch Branch, Division of Translational Medicine, Sidra Medical and Research Center, Doha, QatarORCID Iconhttp://orcid.org/0000-0002-7649-5092
ORCID Icon,
Giovanni AmatoMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Diego AnnesiMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Davide BedognettiResearch Branch, Division of Translational Medicine, Sidra Medical and Research Center, Doha, QatarORCID Iconhttp://orcid.org/0000-0002-5857-773X
ORCID Icon,
Maresa AltomonteMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Riccardo DanielliMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Luana CalabròMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Anna Maria Di GiacomoMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
,
Francesco M. MarincolaOffice of the Chief Research Officer (CRO), Research Branch, Sidra Medical and Research Center, Doha, Qatar
,
Giorgio ParmianiMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;Italian Network for Bio-therapy of Tumors-(NIBIT)-Laboratory, Siena, Italy
&
Michele MaioMedical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
 show all
Article: e1323618 | Received 03 Feb 2017, Accepted 21 Apr 2017, Published online: 20 Jun 2017

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ernest Y. Lee & Rajan P. Kulkarni. (2019) Circulating biomarkers predictive of tumor response to cancer immunotherapy. Expert Review of Molecular Diagnostics 19:10, pages 895-904.
Read now
Alejandro López-Soto, Segundo Gonzalez & Lorenzo Galluzzi. (2017) Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade. OncoImmunology 6:10.
Read now

Articles from other publishers (30)

Shayista Akbar, Afsheen Raza, Reyad Mohsin, Aladdin Kanbour, Shahnaz Qadri, Aijaz Parray, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar, Maysaloun Merhi, Shereena Hydrose, Varghese Philipose Inchakalody, Rajaa Al-Abdulla, Wafa Abualainin, Shaza Abu Sirriya, Issam Al-Bozom, Shahab Uddin, Omar Muhammad Khan, Mohamed Izham Mohamed Ibrahim, Ussama Al Homsi & Said Dermime. (2023) Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients. Frontiers in Immunology 13.
Crossref
Silvia López-Borrego, Carmen Campos-Silva, Amaia Sandúa, Tamara Camino, Lucía Téllez-Pérez, Estibaliz Alegre, Alexandra Beneitez, Ricardo Jara-Acevedo, Annette Paschen, María Pardo, Álvaro González & Mar Valés-Gómez. (2023) MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated. Frontiers in Cell and Developmental Biology 10.
Crossref
Veronika Voronova, Anastasia Vislobokova, Kerim Mutig, Mikhail Samsonov, Kirill Peskov, Marina Sekacheva, Maria Materenchuk, Natalya Bunyatyan & Svetlana Lebedeva. (2022) Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance. Frontiers in Oncology 12.
Crossref
Guo-Tian Ruan, Hai-Lun Xie, Li-Chen Zhu, Yi-Zhong Ge, Lin Yan, Cun Liao, Yi-Zhen Gong & Han-Ping Shi. (2022) Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis. Frontiers in Genetics 13.
Crossref
Jingping Zhou, Shaolong Zhang & Changying Guo. (2021) Crosstalk between macrophages and natural killer cells in the tumor microenvironment. International Immunopharmacology 101, pages 108374.
Crossref
Charlotte Pilard, Marie Ancion, Philippe Delvenne, Guy Jerusalem, Pascale Hubert & Michael Herfs. (2021) Cancer immunotherapy: it’s time to better predict patients’ response. British Journal of Cancer 125:7, pages 927-938.
Crossref
Afsheen Raza, Maysaloun Merhi, Allan Relecom, Queenie Fernandes, Varghese Inchakalody, Abdul Rahman Zar Gul, Shahab Uddin, Mohammed Ussama Al Homsi & Said Dermime. 2021. Advances in Precision Medicine Oncology. Advances in Precision Medicine Oncology.
Sara Tomei, Ola Ibnaof, Shilpa Ravindran, Soldano Ferrone & Cristina Maccalli. (2021) Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs. Cancers 13:7, pages 1674.
Crossref
Milena Ivanova & Velizar Shivarov. (2020) HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started. International Journal of Immunogenetics 48:2, pages 193-200.
Crossref
Hansol Lee, Inês Pires Da Silva, Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long & James S. Wilmott. (2021) Targeting NK Cells to Enhance Melanoma Response to Immunotherapies. Cancers 13:6, pages 1363.
Crossref
Nguyen Hoang Viet, Nguyen Quang Trung, Le Thanh Dong, Ly Quoc Trung & J. Luis Espinoza. (2021) Genetic variants in NKG2D axis and susceptibility to Epstein–Barr virus-induced nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 147:3, pages 713-723.
Crossref
Fahmin Basher, Payal Dhar, Xin Wang, Derek A. Wainwright, Bin Zhang, Jeffrey Sosman, Zhe Ji & Jennifer D. Wu. (2020) Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. Journal of Hematology & Oncology 13:1.
Crossref
Huan Luo, Chao Ma, Jinping Shao & Jing Cao. (2020) Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma. Frontiers in Oncology 10.
Crossref
G. Karakousis. (2019) Immune checkpoint blockade: an urgent call for biomarkers to help guide treatment. British Journal of Dermatology 182:5, pages 1085-1086.
Crossref
Jinyu Zhang, Pablo Saenz-lopez Larrocha, Bin Zhang, Derek Wainwright, Payal Dhar & Jennifer D. Wu. (2019) Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay & Christophe Caux. (2019) Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Shilpa Ravindran, Saad Rasool & Cristina Maccalli. (2019) The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy. Cancer Microenvironment 12:2-3, pages 133-148.
Crossref
Dongkui Song, Thomas Powles, Lei Shi, Lirong Zhang, Molly A Ingersoll & Yong‐Jie Lu. (2019) Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches. The Journal of Pathology 249:2, pages 151-165.
Crossref
Adeline N. Boettcher, Ahmed Usman, Alicia Morgans, David J. VanderWeele, Jeffrey Sosman & Jennifer D. Wu. (2019) Past, Current, and Future of Immunotherapies for Prostate Cancer. Frontiers in Oncology 9.
Crossref
Yoshiyuki Nakamura. (2019) Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events. Frontiers in Medicine 6.
Crossref
Alexandra Frazao, Louise Rethacker, Meriem Messaoudene, Marie-Françoise Avril, Antoine Toubert, Nicolas Dulphy & Anne Caignard. (2019) NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment. Frontiers in Immunology 10.
Crossref
Fausto Petrelli, Raffaele Ardito, Barbara Merelli, Veronica Lonati, Mary Cabiddu, Silvia Seghezzi, Sandro Barni & Antonio Ghidini. (2019) Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Research 29:1, pages 1-12.
Crossref
Sheila López-Cobo, Carmen Campos-Silva, Amanda Moyano, Myriam Oliveira-Rodríguez, Annette Paschen, María Yáñez-Mó, María Carmen Blanco-López & Mar Valés-Gómez. (2018) Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma. Journal of Nanobiotechnology 16:1.
Crossref
Claire Lhuillier, Claire Vanpouille-Box, Lorenzo Galluzzi, Silvia Chiara Formenti & Sandra Demaria. (2018) Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in Cancer Biology 52, pages 125-134.
Crossref
Marie-Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, René J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher L. Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein Tawbi, Michael K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard Royal, Janice N. Cormier, Jennifer A. Wargo, Laszlo G. Radvanyi, Carlos A. Torres-Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria & Chantale Bernatchez. (2018) Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome. Clinical Cancer Research 24:18, pages 4416-4428.
Crossref
Dominik Schmiedel & Ofer Mandelboim. (2018) NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy. Frontiers in Immunology 9.
Crossref
Sam Sheppard, Amir Ferry, Joana Guedes & Nadia Guerra. (2018) The Paradoxical Role of NKG2D in Cancer Immunity. Frontiers in Immunology 9.
Crossref
Lorenzo Pilla & Cristina Maccalli. (2018) Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges. Biomedicines 6:3, pages 76.
Crossref
Kristina Buder-Bakhaya & Jessica C. Hassel. (2018) Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond. Frontiers in Immunology 9.
Crossref
Payal Dhar & Jennifer D Wu. (2018) NKG2D and its ligands in cancer. Current Opinion in Immunology 51, pages 55-61.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.